| Thu, Oct 2, 2008 | | • | Israel Stocks: Market lower, reopening after holiday; Strauss gets a buy rating
at MarketWatch (Thu, Oct 2)
| | Wed, Oct 1, 2008 | | • | 5-Star Stocks Poised to Pop: Teva Pharmaceutical
at Motley Fool (Wed, Oct 1)
| | Tue, Sep 30, 2008 | | • | Mutual Fund Ratings: 10 Biggest Upgrades, Downgrades
at TheStreet.com (Tue, Sep 30)
| | • | A Top BioMarin Drug Heads Overseas
at Motley Fool (Tue, Sep 30)
| | Mon, Sep 29, 2008 | | • | An Overnight 2-Bagger
at Motley Fool (Mon, Sep 29)
| | Thu, Sep 25, 2008 | | • | Teva Heads to Japan
at Motley Fool (Thu, Sep 25)
| | • | Ready and Willing, but Unable? Survey Reveals Boomers Desire Sex, But Face Physical Challenges
PR Newswire (Thu, Sep 25)
| | Wed, Sep 24, 2008 | | • | Sanofi Gets the Golden Ring
at Motley Fool (Wed, Sep 24)
| | • | [$$] At CVS Golf Gala, Suppliers Pay for Access to Executives
at The Wall Street Journal Online (Wed, Sep 24)
| | Tue, Sep 23, 2008 | | • | [$$] Field Opens for M&A Risk-Takers
at The Wall Street Journal Online (Tue, Sep 23)
| | Mon, Sep 22, 2008 | | • | UPDATE - RESEARCH ALERT-Wachovia raises US generic drug sector
at Reuters (Mon, Sep 22)
| | • | Ahead of the Bell: Generic drug makers
AP (Mon, Sep 22)
| | Fri, Sep 19, 2008 | | • | More consolidation seen in generic drug industry
AP (Fri, Sep 19)
| | • | UPDATE - Teva exec knocks down Stada acquisition reports
at Reuters (Fri, Sep 19)
| | • | Wealth & Wellness
at Forbes.com (Fri, Sep 19)
| | Thu, Sep 18, 2008 | | • | Citi names Lehman exec to run merger department
AP (Thu, Sep 18)
| | • | Ranbaxy's Troubles Won't Help Competitors
at Motley Fool (Thu, Sep 18)
| | Wed, Sep 17, 2008 | | • | Wary companies put M&A deals on hold
at FT.com (Wed, Sep 17)
| | Tue, Sep 16, 2008 | | • | Who Might Replace Lehman, Merrill in S&P 500?
at Barron's Online (Tue, Sep 16)
| | • | Barr Receives Approval for Generic Version of Razadyne(R) ER Capsules
PR Newswire (Tue, Sep 16)
|
Add BRL News to My Yahoo!:
 
| |
|
1.94% Nasdaq 
Headlines
